- Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis
Igor Henrique Rodrigues de Paiva et al, 2024, Journal of Neuroimmune Pharmacology CrossRef - Experimental Assessment of Intestinal Damage in Controlled Donation After Circulatory Death for Visceral Transplantation
Pablo Stringa et al, 2023, Transplant International CrossRef - TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
Xiaolong Zhao et al, 2024, Open Life Sciences CrossRef - Rivaroxaban Modulates TLR4/Myd88/NF-Kβ Signaling Pathway in a Dose-Dependent Manner With Suppression of Oxidative Stress and Inflammation in an Experimental Model of Depression
Walaa Yehia Abdelzaher et al, 2021, Frontiers in Pharmacology CrossRef - Atorvastatin Upregulates microRNA-186 and Inhibits the TLR4-Mediated MAPKs/NF-κB Pathway to Relieve Steroid-Induced Avascular Necrosis of the Femoral Head
Yusong Zhang et al, 2021, Frontiers in Pharmacology CrossRef - Review article: current and emerging therapies for acute alcohol‐associated hepatitis
Puru Rattan et al, 2022, Alimentary Pharmacology & Therapeutics CrossRef